Federal contractor · DETROIT, MI

ASTERAND US ACQUISTION CORPORATION

No contract obligations recorded for ASTERAND US ACQUISTION CORPORATION in FY2026. Since FY2017: -$852.1K.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
D8DBNBJL5MY7
Parent company
BIOIVT, LLC
Small business

Company family

Grouped from reported parent companies (UEI) and, where marked, AI judgments that two records name the same organization or group.

Part of the BIOIVT, LLC company family: 2 registered entities, $53.5K in FY2026 together. See the family

  1. BIOIVT, LLCWOODBURY, NY · Family page
    $53.5K

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 324.3KFY2017
  2. -658.1KFY2018
  3. 105.8KFY2019
  4. -527.9KFY2021
  5. -96.2KFY2023

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for ASTERAND US ACQUISTION CORPORATION in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

No subawards reported to other companies.

Primes that pay it

1 company · $222K reported

  1. MENLO PARK, CA · 2 subawards · Scientific research and development services

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from 2021.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 7 markets (agency × industry), FY2024–FY2026.

  1. INSPHERO, INC$256.6K−100% in FY2026
    BRUNSWICK, ME · 33% of this company's obligations are in markets they both serveNational Institutes of Health · Architectural, engineering, and related servicesNational Institutes of Health · Pharmaceutical and medicine manufacturing
  2. BIO-TECHNE SALES CORPORATION$248.7K−77% in FY2026
    MINNEAPOLIS, MN · 28% of this company's obligations are in markets they both serveDefense Health Agency · Pharmaceutical and medicine manufacturingNational Institutes of Health · Pharmaceutical and medicine manufacturingCenters for Disease Control and Prevention · Pharmaceutical and medicine manufacturing
  3. VIRALGEN VECTOR CORE SL$656.9K−99% in FY2026
    DONOSTIA-SAN SEBASTIAN, ESP · 37% of this company's obligations are in markets they both serveNational Institutes of Health · Architectural, engineering, and related servicesNational Institutes of Health · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.